Skip to content
Dose Brief
Menu

Briefs · page 6 of 14

GLP-1 provider reviews

Compare our rated directory using the Brief Score — price stability, supply reliability, transparency and access.

Showing 201–240 of 546 rated-directory entries. Most recent verification in the ranking: .

Grade C and below

Tracked and scored — read the caveats.

Status assessments

Current prescription availability needs confirmation; retained scores describe earlier listings.

Brief Scores are our editorial judgment per the methodology; facts reflect each provider's public disclosures at last check. A commission never changes a score, and it never softens what we write about a provider. What it does move is position: this index runs in ranking order, and providers we have a commercial relationship with sit ahead of providers we do not. Weigh the write-up, not the slot — see our disclosure. Not medical advice.

The desk's No. 201 · 68/100

Premium Health

Premium Health lists monthly base rates and higher-strength surcharges. Confirm your refill schedule and how much notice you need to cancel.

FDA warning letter, February 2026 — issued to Premium Health Management Inc. dba Premium Health. See the FDA's warning letter database.

Semaglutide
$275/mo base rate. Premium Health lists an additional $100/mo at a higher prescribed strength.
Tirzepatide
$445/mo base rate. Premium Health lists an additional $150/mo at a higher prescribed strength.
Visit Premium Health ↗
Full brief →Ad disclosure — we may earn a commission.

Shopping on price?

See every provider with its price direction and the note behind it.

Open the ranking →